Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2025 Earnings Call Transcript February 26, 2026
Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.57 EPS, expectations were $0.85.
Operator: Good day, and thank you for standing by. Welcome to the Q4 2025 Pacira BioSciences, Inc. Earnings Conference Call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. To ask a question during the session,...
